Clinical Trial Update: This Trial is a Prospective Observational Study of Newly Diagnosed Diffuse Large B Cell Primary Breast Lymphomas

View source ↗

Summary

A prospective observational study on newly diagnosed diffuse large B-cell lymphoma of the breast sponsored by IELSG has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma of the Breast

Snippet

Sponsor: International Extranodal Lymphoma Study Group (IELSG) | Conditions: Diffuse Large B-Cell Lymphoma of the Breast | Status: TERMINATED